Dicot Pharma AB (STO: DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.291
-0.032 (-9.91%)
At close: Jan 20, 2025
-20.49%
Market Cap 517.62M
Revenue (ttm) n/a
Net Income (ttm) -52.66M
Shares Out 1.78B
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,476,949
Average Volume 9,560,673
Open 0.318
Previous Close 0.323
Day's Range 0.291 - 0.321
52-Week Range 0.096 - 0.576
Beta 1.35
RSI 64.83
Earnings Date Feb 27, 2025

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.